Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative indocyanine green inhalation for pleural defect imaging in VATS anatomical lung resection
ChiCTR2300067603Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of indocyanine green in lung nodule (SPN) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Postoperative air leak rate. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
lung nodule (SPN)
Beyond the preview
Go deeper on ChiCTR2300067603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067603.